M. Akamatsu

FGF-2 Stimulates Periodontal Regeneration

H. Shimauchi, R. Sakagami, S. Takashiba, 2011, Journal of dental research.

A phase 3, multicenter, randomized, double‐blind, vehicle‐controlled, parallel‐group study of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis

A. Kume, H. Yokozeki, Shinichi Takayama, 2021, The Journal of dermatology.

Randomized Placebo‐Controlled and Controlled Non‐Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects

Y. Izumi, H. Shimauchi, R. Sakagami, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A phase III, 52‐week, open‐label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis

A. Kume, H. Yokozeki, T. Hanafusa, 2021, The Journal of dermatology.

Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children.

J. Okamura, Y. Nagatoshi, H. Tasaka, 1997, International journal of hematology.

Randomized Placebo‐Controlled and Controlled Non‐Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects

Y. Izumi, H. Shimauchi, R. Sakagami, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.